The Medicines Company to Participate in the Bank of America Merrill Lynch 2019 Healthcare Conference

PARSIPPANY, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24MDCO&src=ctag" target="_blank"gt;$MDCOlt;/agt;–The Medicines Company (NASDAQ:MDCO) announced that it will participate
in the Bank of America Merrill Lynch 2019 Healthcare Conference on
Tuesday, May 14, 2019, in Las Vegas. The Company is scheduled to present
at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time).

A live audio webcast will be available on The
Medicines Company Investor Relations website and a replay of the
presentation will be available within 48 hours of the event.

About The Medicines Company

The Medicines Company is a biopharmaceutical company whose purpose is to
halt the deadly progression of atherosclerosis and the cardiovascular
risk created by high levels of LDL-C, or bad cholesterol. Our team is
focused on transformational solutions that address the daily challenges
that patients, physicians and payers confront in cardiovascular care.
The Company is headquartered in Parsippany, New Jersey. For more
information, please visit www.themedicinescompany.com
and follow us on Twitter @MDCONews
and LinkedIn.

Contacts

Investor Relations
Krishna Gorti, M.D.
Vice President,
Investor Relations
973 290 6122
krishna.gorti@themedco.com

Media Inquiries
Michael Blash
Vice President,
Communications
973 290 6100
michael.blash@themedco.com